TAVR in patients with severe aortic stenosis and less than high risk: Future or present reality?
TAVR use is growing in patients with less than high surgical risk. Several registries, including this one, show excellent safety with TAVR in intermediate-risk patients compared with similar patients undergoing SAVR. Long-term data from ongoing randomized trials will answer definitively if we should routinely perform TAVR in intermediate-risk patients.